Literature DB >> 6346491

Hemophilus influenzae septic arthritis in adults.

G Ho, J J Gadbow, S L Glickstein.   

Abstract

Hemophilus influenzae is an important but uncommon cause of adult septic arthritis. We report two cases and review 23 previously published cases. Two-thirds of the patients had systemic diseases, local factors, or both which predisposed them to septic arthritis. The acute disease was monarticular in 48%, polyarticular in 24%, and accompanied by tenosynovitis and/or bursitis in 28% of cases. Extraarticular sites of H. influenzae infection were found in 60% of cases. These sites represented either likely portals of bacterial entry or foci of infection resulting from hematogenous dissemination of H. influenzae. The most characteristic synovial fluid finding was the presence of Gram-negative pleomorphic microorganism. However, misinterpretation of the Gram-stained smear was common and led to an erroneous initial diagnosis in several instances. Prompt sterilization of the infected synovial fluid was the rule once an appropriate antimicrobial agent was administered. A favorable outcome was reported in 88% of cases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6346491     DOI: 10.1016/0049-0172(83)90012-4

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  3 in total

Review 1.  Haemophilus influenza septic arthritis in the adult.

Authors:  M Bonet Llorach; D Arnam Fernandez; J Valles Daunis; J Maymo Guarch; J Carbonell Abelló
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

2.  Arthritis caused by Haemophilus paraphrophilus and isolation of the organism by using an improved culture protocol.

Authors:  R von Essen; A A Kostiala; I Anttolainen; J Haapasaari; A Sivonen
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

Review 3.  Multiple myeloma presenting with Hemophilus influenzae septic arthritis: case report and review of the literature.

Authors:  V Berthaud; J Milder; W el-Sadr
Journal:  J Natl Med Assoc       Date:  1993-08       Impact factor: 1.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.